Parallel Advisors, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,808
+71.3%
440
+61.8%
0.00%
Q2 2023$9,811
+94.6%
272
+106.1%
0.00%
Q1 2023$5,041
-42.8%
132
-14.8%
0.00%
Q4 2022$8,820
-19.8%
155
-44.2%
0.00%
-100.0%
Q3 2022$11,000
+22.2%
278
+42.6%
0.00%
Q2 2022$9,000
+50.0%
195
+25.0%
0.00%
Q1 2022$6,0000.0%156
+12.2%
0.00%
Q4 2021$6,000
-57.1%
139
-59.9%
0.00%
-100.0%
Q3 2021$14,000
+250.0%
347
+273.1%
0.00%
Q2 2021$4,000
-33.3%
93
-38.8%
0.00%
Q1 2021$6,000
+50.0%
152
+63.4%
0.00%
Q4 2020$4,000
-42.9%
93
-65.3%
0.00%
Q3 2020$7,0000.0%2680.0%0.00%
Q2 2020$7,000
+133.3%
268
+45.7%
0.00%
Q1 2020$3,0000.0%184
+5.1%
0.00%
Q4 2019$3,0000.0%1750.0%0.00%
Q3 2019$3,0000.0%1750.0%0.00%
Q2 2019$3,0001750.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders